Literature DB >> 21681633

Japanese encephalitis (JE) part II: 14 years' follow-up of survivors.

N B S Sarkari1, A K Thacker, S P Barthwal, V K Mishra, Shiv Prapann, Deepak Srivastava, M Sarkari.   

Abstract

Japanese encephalitis, the commonest Arbovirus encephalitis, has been endemic in many parts of Asia, the Pacific Islands, and India; also, there have been many epidemics. Most of the post JE cases have been associated with neurological and neuropsychiatric deficits but have not been properly classified and followed. Practically all the previous studies were in children or young adults. The aim of this study, involving only adult cases, the largest ever being reported, has been to follow the 688/1,199 survivors of JE patients out of 1,282 of acute cases admitted during four epidemics for a period of 14 years after properly classifying the sequelae. This prospective study was conducted in B.R.D. Medical College Gorakhpur (India), involving 665/688 post JE cases with neuropsychiatric deficits from four epidemics of 1978, 1980, 1988 and 1989 which were properly classified in nine groups. While the first epidemic of 1978 was being studied, more disastrous episodes flared up and the patients were subsequently added. Hence, the total duration of this prospective study was from November 1978 to December 2003. There were 14 defaulted initially from 688 followed (23/688 without sequelae and 665/688 with neuropsychiatric deficits), and later 130 were lost from time to time at various stages of follow up. Four out of 23/688 discharged without any deficit had to be readmitted for bizarre movements, assaultative behaviour and euphoria without fever and altered sensorium. All of them improved by symptomatic treatment. Progressive improvement occurred in all the parameters consisting of psychological disturbances, higher cerebral dysfunction, speech disorders (dysphonia, dysarthria, dysphasias, apraxia and agnosia), extra pyramidal, pyramidal features, and hypothalamic disturbances, cranial nerves including pupils and fundi and seizures. Maximum cases improved between 6 months (55%) to 1 year (78%). Only some features improved between 5 to 14 years. Four patients of hemiplegia remained bed ridden. Some non disabling features like dysarthria and corticospinal features without paralysis persisted in 5% (95% improved) and 74% (26% improved) respectively. One patient with bizarre movement and nine with marked tremors could not regain normalcy. A large number of patients of JE are left with several minor or gross residual neuropsychiatric and neurological features after the acute phase. In this series also the discharged patients with neurological deficits who were quite disabled initially and needed constant care by family members and also those who required some help intermittently improved with passage of time and eventually returned to normal life. Some of them were left with non-disabling residual neurological signs even after 14 years. Fourteen of 544 (3%) could not return to their livelihood.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21681633     DOI: 10.1007/s00415-011-6131-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

Review 1.  Japanese encephalitis.

Authors:  P N Rao
Journal:  Indian Pediatr       Date:  2001-11       Impact factor: 1.411

2.  JAPANESE ENCEPHALITIS IN TAIWAN: A REVIEW OF RECENT STUDIES.

Authors:  S P WANG
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

3.  Neurologic sequelae of Japanese B encephalitis.

Authors:  R W RICHTER; S SHIMOJYO
Journal:  Neurology       Date:  1961-07       Impact factor: 9.910

4.  Sequelae of Japanese B and mumps encephalitis: recent follow-up of patients affected in 1947-1948 epidemic on Guam.

Authors:  S J PIEPER; L T KURLAND
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

5.  Clinical profile of the epidemic of Japanese encephalitis at Bankura.

Authors:  S N Sen Gupta; M K Sen; P K Das; D P Bhattacharya; B B Rath
Journal:  Indian J Med Res       Date:  1976-10       Impact factor: 2.375

6.  Sequelse of Japanese B encephalitis.

Authors:  T W SIMPSON; G MEIKLEJOHN
Journal:  Am J Trop Med Hyg       Date:  1947-11       Impact factor: 2.345

7.  Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis.

Authors:  Tom Solomon; Nguyen Minh Dung; Rachel Kneen; Le Thi Thu Thao; Mary Gainsborough; Ananda Nisalak; Nicholas P J Day; Fenella J Kirkham; David W Vaughn; Shelagh Smith; Nicholas J White
Journal:  Brain       Date:  2002-05       Impact factor: 13.501

8.  Long-term disability from acute childhood Japanese encephalitis in Shanghai, China.

Authors:  Ding Ding; Zhen Hong; Shou-Jun Zhao; John D Clemens; Bin Zhou; Bei Wang; Mao-Sheng Huang; Jun Zeng; Qi-Hao Guo; Wei Liu; Fang-Biao Tao; Zhi-Yi Xu
Journal:  Am J Trop Med Hyg       Date:  2007-09       Impact factor: 2.345

9.  JAPANESE ENCEPHALITIS IN THE USSR.

Authors:  N I GRASCENKOV
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

10.  The epidemiology, clinical features, and long-term prognosis of Japanese encephalitis in central sarawak, malaysia, 1997-2005.

Authors:  Mong How Ooi; Penny Lewthwaite; Boon Foo Lai; Anand Mohan; Daniela Clear; Lina Lim; Shekhar Krishnan; Teresa Preston; Chae Hee Chieng; Phaik Hooi Tio; See Chang Wong; Jane Cardosa; Tom Solomon
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

View more
  13 in total

Review 1.  Video Anthology of Movement Disorders Due to Infections in South Asia.

Authors:  Annu Aggarwal; Sachin Adukia; Mohit Bhatt
Journal:  Mov Disord Clin Pract       Date:  2021-07-18

2.  Acute transverse myelitis following Japanese encephalitis viral infection: an uncommon complication of a common disease.

Authors:  Rajesh Verma; Heramba Narayan Praharaj; Tushar B Patil; Prithvi Giri
Journal:  BMJ Case Rep       Date:  2012-09-24

3.  Comparison of genotypes I and III in Japanese encephalitis virus reveals distinct differences in their genetic and host diversity.

Authors:  Na Han; James Adams; Ping Chen; Zhen-yang Guo; Xiang-fu Zhong; Wei Fang; Na Li; Lei Wen; Xiao-yan Tao; Zhi-ming Yuan; Simon Rayner
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

Review 4.  Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus.

Authors:  Carlo Amorin Daep; Jorge L Muñoz-Jordán; Eliseo Alberto Eugenin
Journal:  J Neurovirol       Date:  2014-10-07       Impact factor: 2.643

Review 5.  Estimating the burden of Japanese encephalitis virus and other encephalitides in countries of the mekong region.

Authors:  Arnaud Tarantola; Flavie Goutard; Paul Newton; Xavier de Lamballerie; Olivier Lortholary; Julien Cappelle; Philippe Buchy
Journal:  PLoS Negl Trop Dis       Date:  2014-01-30

Review 6.  Review of Emerging Japanese Encephalitis Virus: New Aspects and Concepts about Entry into the Brain and Inter-Cellular Spreading.

Authors:  Luis Filgueira; Nils Lannes
Journal:  Pathogens       Date:  2019-07-26

7.  Adults with severe Japanese encephalitis: a retrospective analysis of 9 cases in Linyi, China.

Authors:  Qi Su; Zhong-Xiang Xie; Feng He; Zhen-Chuan Liu; Xiao-Jie Song; Fu-Chun Zhao; Dibin Li; Feng-Yuan Che
Journal:  Neurol Sci       Date:  2020-11-09       Impact factor: 3.307

8.  Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І.

Authors:  Ping Qian; Xianwei Zhi; Bo Wang; Huawei Zhang; Huanchun Chen; Xiangmin Li
Journal:  Virol J       Date:  2015-12-10       Impact factor: 4.099

Review 9.  Neurological Manifestations of Dengue Infection.

Authors:  Guo-Hong Li; Zhi-Jie Ning; Yi-Ming Liu; Xiao-Hong Li
Journal:  Front Cell Infect Microbiol       Date:  2017-10-25       Impact factor: 5.293

Review 10.  Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.

Authors:  Rodolfo Furlan Damiano; Bruno F Guedes; Cristiana Castanho de Rocca; Antonio de Pádua Serafim; Luiz Henrique Martins Castro; Carolina Demarchi Munhoz; Ricardo Nitrini; Geraldo Busatto Filho; Eurípedes Constantino Miguel; Giancarlo Lucchetti; Orestes Forlenza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-06-25       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.